Screening for Albuminuria

A quick pocket tool to help medical professionals assess and treat albuminuria in people with diabetes and other high risk patients. Designed for rapid, convenient, point-of-care intervention whenever and wherever you need it. Content is adapted from KDOQI evidence-based clinical practice guidelines and recommendations from the National Kidney Foundation. Features: Designed for rapid, convenient, point-of-care intervention. With a few quick taps, you will:•Evaluate diabetic patients for albuminuria and chronic kidney disease (CKD) •Use evidence-based strategies to assess and treat •Access an interactive, clinical action plan that can be individualized for your patients Simple, quick, and organized by: •What is Albuminuria? •Why screen for albuminuria in high risk patients? •When to screen •How to screen •Follow-up using a simple, interactive decision-making algorithm •Facts about albuminuria, diabetes, and chronic kidney disease Facts About Chronic Kidney Disease •Kidney disease is common, harmful, and treatable. •26 million American have kidney disease – but most do not know they have it. Millions more are at increased risk. •High risk groups include those with diabetes, hypertension, and a family history of kidney disease. African Americans, Hispanics, Asian or Pacific Islanders, Native Americans and seniors are also at increased risk. •Early detection can slow the progression of kidney disease. •Once kidneys fail, patients need dialysis or a transplant to survive. What is the National Kidney Foundation? The National Kidney Foundation (NKF), a major voluntary nonprofit health organization, is dedicated to preventing kidney and urinary tract disease, improving the health and well-being of individuals and families affected by these diseases and increasing the availability of all organs for transplantation. NKF’s Kidney Disease Outcomes Quality Initiative (KDOQI)® has developed and disseminated 12 clinical practice guidelines for the care of people at all stages of CKD. The NKF also manages an international organization, KDIGO, which is dedicated to improving outcomes for CKD patients worldswide. Thousands of health care professionals join the NKF as members and attend the annual NKF Spring Clinical Meetings. The NKF also publishes four respected, peer-reviewed scientific journals. 30 East 33rd Street New York, NY 10016 www.kidney.org 800-622-9010 This program is made possible by a grant from Boehringer Ingelheim Pharmaceuticals, Inc.